A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer
Clinical trial NCT00134706 · COMPLETED
Trial details
- NCT number
- NCT00134706
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Primary completion
- 2006-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.